These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 6498825

  • 1. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115.
    Noguchi S, Kitamura Y, Uchida N, Yamaguchi K, Sato B, Matsumoto K.
    Cancer Res; 1984 Dec; 44(12 Pt 1):5644-9. PubMed ID: 6498825
    [Abstract] [Full Text] [Related]

  • 2. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S, Nishizawa Y, Nakamura N, Uchida N, Yamaguchi K, Sato B, Kitamura Y, Matsumoto K.
    Cancer Res; 1987 Jan 01; 47(1):263-8. PubMed ID: 3791211
    [Abstract] [Full Text] [Related]

  • 3. Stimulative effect of physiological doses of androgen or pharmacological doses of estrogen on growth of Shionogi carcinoma 115 in mice.
    Noguchi S, Nishizawa Y, Uchida N, Yamaguchi K, Sato B, Kitamura Y, Matsumoto K.
    Cancer Res; 1985 Nov 01; 45(11 Pt 2):5746-50. PubMed ID: 4053046
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of estrogen enhancement in the growth of androgen-dependent Shionogi carcinoma 115.
    Noguchi S, Takatsuka D, Kitamura Y, Terada N, Uchida N, Yamaguchi K, Sato B, Matsumoto K.
    Cancer Res; 1985 Oct 01; 45(10):4785-90. PubMed ID: 4027967
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y, Sato B, Noma K, Kishimoto S, Koizumi K, Aono T, Matsumoto K.
    Cancer Res; 1983 Sep 01; 43(9):4091-7. PubMed ID: 6871850
    [Abstract] [Full Text] [Related]

  • 6. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents.
    Matsuzawa A, Ikeda Y.
    Cancer Res; 1983 Aug 01; 43(8):3680-6. PubMed ID: 6861137
    [Abstract] [Full Text] [Related]

  • 7. Effect of castration and 17 beta-estradiol pulse on cell proliferation in the uterus and the MXT mouse mammary tumor.
    Paridaens RJ, Danguy AJ, Leclercq G, Kiss R, Heuson JC.
    J Natl Cancer Inst; 1985 Jun 01; 74(6):1239-46. PubMed ID: 3858596
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory and stimulatory effects of glucocorticoid on androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture.
    Hiraoka D, Nakamura N, Nishizawa Y, Uchida N, Noguchi S, Matsumoto K, Sato B.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6560-4. PubMed ID: 3677094
    [Abstract] [Full Text] [Related]

  • 9. Androgen receptor system in androgen-independent mouse tumor developed from androgen-dependent Shionogi carcinoma 115.
    Seike H, Takeuchi M, Kitamura Y, Sato B, Yamaguchi K, Matsumoto K.
    Anticancer Res; 1983 Dec 15; 3(1):35-9. PubMed ID: 6830149
    [Abstract] [Full Text] [Related]

  • 10. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
    Yoshida H, Fukuhara T, Yamashi S, Yoshida A, Fukunishi R, Tsuji M, Matsumoto K.
    Cancer Res; 1983 May 15; 43(5):2311-6. PubMed ID: 6403234
    [Abstract] [Full Text] [Related]

  • 11. Growth-stimulating effect of pharmacological doses of glucocorticoid on androgen-responsive Shionogi carcinoma 115 in vivo in mice and in cell culture.
    Omukai Y, Nakamura N, Hiraoka D, Nishizawa Y, Uchida N, Noguchi S, Sato B, Matsumoto K.
    Cancer Res; 1987 Aug 15; 47(16):4329-34. PubMed ID: 3607765
    [Abstract] [Full Text] [Related]

  • 12. [Stimulation and inhibition of the growth of sex-steroid-dependent tumors].
    Matsumoto K, Nakamura N, Sato B.
    Gan To Kagaku Ryoho; 1987 Mar 15; 14(3 Pt 2):771-9. PubMed ID: 3566289
    [Abstract] [Full Text] [Related]

  • 13. Androgen dependency of a tumor produced by a cell line derived from androgen-responsive Shionogi carcinoma 115.
    Terada N, Yamamoto R, Uchida N, Takada T, Taniguchi H, Takatsuka D, Sawada M, Tsuji M, Li W, Kitamura Y.
    Cancer Res; 1989 Feb 01; 49(3):693-8. PubMed ID: 2910490
    [Abstract] [Full Text] [Related]

  • 14. Effect of adjuvant endocrine and adjuvant chemoendocrine therapies on metastasis of androgen-dependent Shionogi carcinoma 115.
    Yoshikawa T, Kitamura Y, Uchida N, Yamaguchi K, Matsumoto K.
    Cancer Res; 1983 Oct 01; 43(10):4525-9. PubMed ID: 6883315
    [Abstract] [Full Text] [Related]

  • 15. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.
    Bruchovsky N, Rennie PS, Coldman AJ, Goldenberg SL, To M, Lawson D.
    Cancer Res; 1990 Apr 15; 50(8):2275-82. PubMed ID: 2317815
    [Abstract] [Full Text] [Related]

  • 16. Mediation by the androgen receptor of the stimulatory and antiandrogenic actions of 17 beta-estradiol on the growth of androgen-sensitive Shionogi mammary carcinoma cells in culture.
    Luthy IA, Bégin D, Labrie F.
    Endocrinology; 1988 Sep 15; 123(3):1418-24. PubMed ID: 3402389
    [Abstract] [Full Text] [Related]

  • 17. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC, Parsons JA.
    Cancer Res; 1981 May 15; 41(5):1772-7. PubMed ID: 7214344
    [Abstract] [Full Text] [Related]

  • 18. Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumor in the rat.
    Ip MM, Milholland RJ, Kim U, Rosen F.
    J Natl Cancer Inst; 1982 Sep 15; 69(3):673-81. PubMed ID: 6955558
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of antibody against basic fibroblast growth factor on androgen- or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture.
    Lu J, Nishizawa Y, Tanaka A, Nonomura N, Yamanishi H, Uchida N, Sato B, Matsumoto K.
    Cancer Res; 1989 Sep 15; 49(18):4963-7. PubMed ID: 2766270
    [Abstract] [Full Text] [Related]

  • 20. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
    Miyake H, Pollak M, Gleave ME.
    Cancer Res; 2000 Jun 01; 60(11):3058-64. PubMed ID: 10850457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.